Ranbaxy Laboratories on Friday said Arun Sawhney has taken over as the Managing Director of the company, replacing Atul Sobti, who resigned on August 12.
Sawhney, who was earlier President, global pharmaceutical business of the company, has been appointed as MD for a period of three years, Ranbaxy said.
He has around three decades of experience in the industry and held senior management positions in several pharmaceutical firms, including Max-Gb, Hindustan Ciba-Geigy, Bayer India Ltd and Dr Reddy’s Laboratories Ltd.
Besides, he is one of the founder members of the Pharmaceuticals Export Promotion Council (Pharmexcil).
His appointment comes after Sobti, who joined the company in 2005 quit from his position as Managing Director and CEO in a surprise development, citing differences with the management of Japanese parent Daiichi Sankyo.
